Susan Pandya

Head of Cancer Metabolism Global Development Oncology & Immuno-Oncology at Servier Pharmaceuticals
On the record

Board certified Hematologist-Oncologist, master clinician with passion for innovation in cancer treatment. Currently, Vice President of Clinical Development at Servier Pharmaceuticals overseeing hematology and oncology clinical development programs. Direct hands-on experience developing novel therapeutics in rare oncology indications and leading teams through successful design, planning, and execution of Phase 1 and Phase 3 global pivotal studies. Extensive experience in leading first in human clinical trials within an academic teaching hospital of Harvard Medical School.

Recent Quotes
Sign up to view all
  • While death rates are decreasing, there has been an increase in diagnoses, with an expected increase of almost 50% by 2050. With the growing population — including the elderly population — and the utilization of advanced imaging diagnostics, which detect earlier stages of cancer and/or more indolent forms of cancer, rates could continue to climb.

    15 February 2022
Sign up to view all